Histopathological study of subacute toxicity of Crocus sativus L. (Saffron) stigma total extract on liver and kidney tissues in the rat

Pharmaceutical Sciences

Volumn 15, Issue 2, 2009, Pages 115-124

  Mohajeri, Daryoush ^a   Mesgari Abbasi, M ^b,c   Delazar, A ^b,c   Doustar, Y ^a   Mousavi, Gh ^a   Amouoghli Tabrizi, B ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crocus sativus L.; Histopathology; Stigma; Subacute toxicity; Total extract

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; CROCUS SATIVUS EXTRACT; HEMOGLOBIN; UREA; URIC ACID;

ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; ERYTHROCYTE COUNT; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; LEUKOCYTE COUNT; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; RAT; STAINING; TISSUE INJURY; TOXICITY TESTING; TOXICOKINETICS; UREA BLOOD LEVEL;

EID: 77958535826     PISSN: 1735403X     EISSN: 23832886     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. De Smet P.A.G.M., Hansel R., Chandler R.F. Adverse Effect of Herbal Drugs, Berlin, Springer-Verlag, 1997, 82.
2. Kafi M. Saffron: Production and Processing, 1st ed. Ferdowsi University of Mashhad, 2003, 21-135&209-275.
3. Ebrahimzade H., Rajabian T., Abrishamchi P., Karamian R., Saboura A. Iranian Saffron from the Research View Point, 1st ed. Ettelaat Publication, 2007, 587-591.
4. Bisset N.G., Wichtl M. Herbal Drugs and Phytopharmaceuticals. A Handbook for Practice on a Scientific Basis, (2ed.), Med. Pharm. Scientific Publisher, CRC Press, London, 2001, 167-169.
5. Abdullaev F.J., Ferenkel G.D. Effects of saffron on cell colony formation and cellular nucleic acid and protein synthesis. Biofactors, 1992, 3: 201-204.
6. Tarantilis P.A., et al. Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus, Anticancer Research, 1994, 14(5A): 1913-1918.
7. Nair S.C., Kurumboor S.K., Hasegawa J.H. Saffron chemoprevention in biology and medicine: A review. Cancer Biother., 1995, 10(4): 257-264.
8. Escribano J., et al. Crocin, safranal and picrocrocin from saffron (Crocus sativus) inhibit the growth of human cancer cells in vitro, Cancer Letters, 1996, 100 (1-2): 23-30.
9. Garcia-Olmo D.C. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus): an experimental study in the rat, Nutrition and Cancer, 1999, 35(2): 120-126.
10. Abdullaev Jafariva J., Caballero-Ortega H., Riveron-Nigrete L., Pereda-miranda R., Rivera-Luna R., Manuel Hernandez J., Perez-Lopez I., Espinosa-Aguirre J.J. In vitro evaluation of chemopreventive potential of saffron., Rev. Inves. Clin., 2002, 54(5): 430-436.
11. Fatehi M., Rashidabady T., Fatehihassanabad Z. Effects of Crous sativus petals extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. Journal of Ethanopharmacology, 2003, 84: 199-203. (Pubitemid 36324260)
12. Hosseinzadeh H., Sadeghnia H.R., Ziaee T., Danaee A. Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. J. Pharm. Pharm. Sci., 2005, 8(3): 387-93.
13. Hosseinzadeh H., Modaghegh M.H., Saffari Z. Crocus Sativus L. (Saffron) Extract and its Active Constituents (Crocin and Safranal) on Ischemia-Reperfusion in Rat Skeletal Muscle. Evidence-based Complementary and Alternative Medicine, 2007, Available at: http://creativecommons.org/licenses/ bync/2.0/uk/.
14. Khori V., Naieb Pour M., Mir Abbasi A., Rakhshan E. The Effect of aqueous extract of Croucus sativus on the basic and functional electrophysiological properties of isolated perfused rabbit AV-Nodal preparation, Journal of Gorgan University of Medical Sciences, 2007, 8(3): 1-7.
15. El Daly E.S. Protective effect of cysteine and vitamin E, Croucus sativus and Nigella sativa Extracts on cisplatin-induced toxicity in rats. J. Pharm. Belg., 1998, 53(2): 87-95.
16. Mohajeri D., Amouoghli Tabrizi B., Mousavi Gh., Mesgari M. Anti-diabetic activity of Crocus sativus L. (Saffron) stigma ethanolic extract in alloxan-induced diabetic rats. Research Journal of Biological Science, 2008, 3(9): 1102-1108.
17. Akhondzadeh S., Fallah-pour H., Afkham K., Khalighi F. Comparison of croucus sativus L. and imipramine mild to moderate depression: A pilot double-blind [ISRCTN45683816] Journal List BMC Complement Altern. Med., 2004, V.4.
18. Salomi M.J., Nair S.C., Panikkar P.R. Cytotoxicity and non-mutagenicity of Nigela sativa and saffron (Crocus sativus) in vitro. Proc. Ker. Sci. Congr., 1991, 5: 244.
19. st Century: Food and Resource Technology Environment. China: Ligth Industry Press, 2000, 185-195.
20. Abdullaev F.I., Caballero Ortega H., Riveron Negrette L., Pereda Iranda R., Hernandez J.M., Perez Lopez J., et al. Use of in vitro assays to assess the potential genotoxic and cytotoxic effects of saffron (Crocus sativus L.). Tox. InVitro, 2003, 17: 731-6.
21. Abdullaev F.I., Espinosa-Aguirre J.J. Biomedical properties of saffron and its potential use in Cancer therapy and chemoprevention trials. Review, Cancer Detection and Prevention, 2004, 28: 426-432.
22. Martin G., Goh E., Neff A.W. Evaluation of the developmental toxicity of crocetin on Xenopus Food and Chemical Toxicology, 2002, 40(7): 959-964.
23. Loomis T.A. Essentials of Toxicology. Philadelphia: Lea and Febiger, 1968, 67-78.
24. Hosseinzadeh H., Khosravan V. Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Irn. Med., 2002, 5: 44-7.
25. Stockham S.L., Scott M.A. Fundamentals of Veterinary Clinical Pathology. First Edition, Iowa State Press. A Blackwell Publishing Company, USA, 2002, 31-48.
26. Latimer K.S., Mahaffey E.A., Prasse K.W. Duncan & Parsse's Veterinary Laboratory Medicine Clinical Pathology. Fourth Edition, Iowa State Press. A Blackwell Publishing Company, USA, 2003, 193-257.
27. Feldman B.F., Zinkl J.G., Jain N.C. Schalm's veterinary hematology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, 2000, 186-298.
28. Noorbala A.A., Akhondzadeh S., Tahmacebi-Pour N., Jamshidi A.H. Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J. Ethnopharm., 2005, 97(2): 281-284. (Pubitemid 40222030)
29. Moshiri E., Akhondzadeh Basti A., Noorbala A.A., Jamshidi A.H., Abbasi S.H., Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A double-blind, randomized and placebo-controlled trial. Phytomed., 2006, 13(9-10): 607-611.
30. Karimi Gh., Taiebi N., Hosseinzadeh H., Shirzad F. Evaluation of subacute toxicity of aqueous extract of Crocus sativus L. stigma and petal in rats. Journal of Medical Plants, Institute of Medical Plants, 2004, 12: 29-35.
31. Whitehead M.W., Hawkes N.D., Hainsworth I., Kingham G.C. A prospective study of the causes of notably raised aspartate transaminase of liver origin, Gut., 1999, 45(1): 129-133. (Pubitemid 29301857)
32. Burtis C.A., Ashwood E.R. Teitz Fundamentals of Clinical Chemistry (4ed.), NB Saunders Company, Philadelphia, 1996, 312-335.
33. Modaghegh M.H., Shahabian M., Esmaeili H.A., Rajbai O., Hosseinzadeh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine, Article in Press.
34. Cullen J.M. Liver, Biliary system, and exocrine pancreas, Pathologic Basis of Veterinary Disease. McGavin MD, Zachary JF Ed.; Forth Edition, Mosby, London, 2007, 403-406.